148 related articles for article (PubMed ID: 25143247)
1. Translational genomics and head and neck cancer: toward precision medicine.
Razzouk S
Clin Genet; 2014 Nov; 86(5):412-21. PubMed ID: 25143247
[TBL] [Abstract][Full Text] [Related]
2. Role of molecular markers in the management of head and neck cancers.
Ferreira MB; De Souza JA; Cohen EE
Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic and genetic alterations-based molecular classification of head and neck cancer.
Feng Z; Xu Q; Chen W
Expert Rev Mol Diagn; 2012 Apr; 12(3):279-90. PubMed ID: 22468818
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of head and neck squamous cell cancer biomarkers.
Polanska H; Raudenska M; Gumulec J; Sztalmachova M; Adam V; Kizek R; Masarik M
Oral Oncol; 2014 Mar; 50(3):168-77. PubMed ID: 24382422
[TBL] [Abstract][Full Text] [Related]
5. Personalized medicine in oncology: tailoring the right drug to the right patient.
Jiang Y; Wang M
Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
[TBL] [Abstract][Full Text] [Related]
6. Genomics and precision surgery for head and neck squamous cell carcinoma.
Galmiche A; Saidak Z; Bouaoud J; Mirghani H; Page C; Dakpé S; Clatot F
Cancer Lett; 2020 Jul; 481():45-54. PubMed ID: 32272147
[TBL] [Abstract][Full Text] [Related]
7. Methylation as a biomarker for head and neck cancer.
Arantes LM; de Carvalho AC; Melendez ME; Carvalho AL; Goloni-Bertollo EM
Oral Oncol; 2014 Jun; 50(6):587-92. PubMed ID: 24656975
[TBL] [Abstract][Full Text] [Related]
8. Clinical applications of genomics in head and neck cancer.
Chung CH; Levy S; Yarbrough WG
Head Neck; 2006 Apr; 28(4):360-8. PubMed ID: 16284976
[TBL] [Abstract][Full Text] [Related]
9. Genetic profile of head and neck squamous cell carcinoma: clinical implications.
Agada FO; Patmore H; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Mar; 123(3):266-72. PubMed ID: 18694533
[TBL] [Abstract][Full Text] [Related]
10. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targets in head and neck squamous cell carcinoma: identification, evaluation, and clinical translation.
Howard JD; Lu B; Chung CH
Oral Oncol; 2012 Jan; 48(1):10-7. PubMed ID: 22020057
[TBL] [Abstract][Full Text] [Related]
12. Harnessing massively parallel sequencing in personalized head and neck oncology.
Jessri M; Farah CS
J Dent Res; 2014 May; 93(5):437-44. PubMed ID: 24557572
[TBL] [Abstract][Full Text] [Related]
13. Precision Therapy of Head and Neck Squamous Cell Carcinoma.
Polverini PJ; D'Silva NJ; Lei YL
J Dent Res; 2018 Jun; 97(6):614-621. PubMed ID: 29649374
[TBL] [Abstract][Full Text] [Related]
14. Molecular biomarkers in HNSCC: prognostic and therapeutic implications.
Hussein MR; Cullen K
Expert Rev Anticancer Ther; 2001 Jun; 1(1):116-24. PubMed ID: 12113118
[TBL] [Abstract][Full Text] [Related]
15. Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice.
Glazer CA; Chang SS; Ha PK; Califano JA
Oral Oncol; 2009; 45(4-5):440-6. PubMed ID: 18674958
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic profiling joins personalized cancer medicine.
Heyn H; Méndez-González J; Esteller M
Expert Rev Mol Diagn; 2013 Jun; 13(5):473-9. PubMed ID: 23782254
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells in head and neck squamous cell cancer.
Prince ME; Ailles LE
J Clin Oncol; 2008 Jun; 26(17):2871-5. PubMed ID: 18539966
[TBL] [Abstract][Full Text] [Related]
18. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
Yarbrough WG
Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
[TBL] [Abstract][Full Text] [Related]
19. The challenge of intratumour heterogeneity in precision medicine.
Seoane J; De Mattos-Arruda L
J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]